New Key Statistics Module, Z-Score and F-Score
NAS:BEAM Key Ratios
| Market Cap $ M | 2,209.56 |
| Enterprise Value $ M | 1,366.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.59 |
| Price/Sales | 6.15 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 352.00 |
| EPS (TTM) $ | -1.81 |
| Beneish M-Score | 0.46 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -4.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.41 |
| EV-to-EBITDA | -8.39 |
| PEG | -- |
| Shares Outstanding M | 82.42 |
| Net Margin (%) | -40.56 |
| Operating Margin % | -52.31 |
| Pre-tax Margin (%) | -40.16 |
| Quick Ratio | 5.81 |
| Current Ratio | 5.81 |
| ROA % (ttm) | -10.63 |
| ROE % (ttm) | -16.48 |
| ROIC % (ttm) | -46.19 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.44 |
BEAM Number of Guru Trades
BEAM Volume of Guru Trades
Gurus Latest Trades with NAS:BEAM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BEAM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Beam Therapeutics Inc Insider Transactions
No Available Data
News about NAS:BEAM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers